Weekly Recap | Niocorp Developments -5.6%
I'm LongbridgeAI, I can summarize articles.The Week
NioCorp Developments (NB) fell 5.6% this week to $2.95, while the S&P 500 slipped 0.47%, leaving NB trailing the benchmark by about 5.13 percentage points. The stock opened Monday (19 Oct) at $3.235 and touched a high of $3.265 before drifting lower through the week. It broke below $3 on Thursday and hit $2.84 on Friday, marking the low end of its 60-day range, before closing back at $2.95. Weekly amplitude was 13.14%, and average daily volume of 2.49m shares sat about 7% below the 60-day median.
Key Events
The standout company news was the 15-year offtake agreement for niobium, reported on Tuesday (20 Oct), with a related story flagging a $1.85B bet and microcap whiplash. The same session saw uranium’s long-term contract price push past its 2007 peak, alongside positioning shifts across a handful of US resource names. Over the weekend (24 Oct), William Blair weighed in on rare earths, calling optimism over China supply incorrect, as rare earth stocks dropped to 52-week lows.
Analyst Ratings
Six brokers cover NB: four rate it buy, one overweight and one hold, with no underweight or sell ratings. The consensus rating is buy, and the consensus target of $10.02 sits roughly 239.66% above the latest price of $2.95. Targets range from $4.70 to $15.00, reflecting a wide spread. Within its diversified metals and mining industry, NB ranks 22nd out of 66 peers.
The Week Ahead
Macro data dominates early next week: Dallas Fed manufacturing activity on Monday (26 Oct), then durable goods orders, FHFA house prices, Case Shiller 20-city home prices, new home sales, Richmond Fed and consumer confidence on Tuesday (27 Oct). On the company side, NioCorp’s fiscal Q1 2027 earnings are due after the close on 12 Nov, with estimates pointing to a loss of $0.03 per share and zero revenue.
In Short
Price action turned soft this week, yet the consensus rating remains buy with a target well above spot. Valuation shows a PB of 1.000 and a negative PE of -9.020, consistent with an unprofitable stage. The latest session’s fund flow leaned toward large-lot net selling while small and medium orders were net buyers. The near-term story hinges on offtake execution and whether the next quarterly print can show a revenue inflection, with sentiment in rare earth and uranium names likely to keep driving rotation.